New York-based firm Weber Shandwick has been responsible for elevating Pfizer’s profile since at least 2006. It partnered with Moderna in June this year, after the small biotech firm became a household name following its vaccine success.
Yet questions are being raised about a possible conflict of interest as it emerged the company was hired by the Centers for Disease Control and Prevention (CDC) during the pandemic to boost its ‘health communication’.
It was involved in PR campaigns that encouraged Americans to get vaccinated against Covid.
But a spokesperson for Weber Shandwick toldit had a ‘thorough vetting and mitigation process to avoid conflicts’.
Vaccine makers made more than $34billion in profits last year from the Covid jabs alone — equivalent to $1,000 a second, according to estimates.
They are expected to make billions more from the bivalent booster jabs being rolled out this winter — with the US having bought 171million doses.
Today the updated shots — which tackle Omicron variants — got the green light for children as young as five years old. They are currently recommended for all over-12s.